The British Journal of Radiology, Vol 62, Issue 744 1079-1083, Copyright © 1989 by British Institute of Radiology

ARTICLES

Modulation in the radiosensitivity of MCF-7 human breast carcinoma cells by 17B-estradiol and tamoxifen

DE Wazer, OF Tercilla, PS Lin and R Schmidt-Ullrich
Department of Radiation Oncology, New England Medical Center Hospital, Tufts University School of Medicine, Boston, Massachusetts 02111.

Colony-forming ability after exposure to ionizing irradiation was compared for proliferating hormone response MCF-7 breast carcinoma cells and cells whose growth was inhibited by tamoxifen or 17B-estradiol. As compared with controls (Do = 1.20 Gy, n = 3.1), cells in 1 microM or 5 microM tamoxifen were less radiosensitive (Do = 1.20 Gy, n = 7.0; Do = 1.22 Gy, n = 7.0, respectively) with the predominant effect being a widened shoulder on the survival curve. This protective effect could be abolished by co-incubation of 5 microM tamoxifen with 100 nM 17B-estradiol (Do = 1.30 Gy, n = 2.6; Do = 1.20 Gy, n = 2.6, respectively). The decrease in radiosensitivity induced by tamoxifen was similar to that seen when replating of irradiated plateau-phase cultures was delayed for 24 h (Do = 1.30 Gy, n = 6.0). In contrast, when proliferation of MCF-7 cultures was inhibited by 10 microM 17B-estradiol, radiosensitivity was increased with a markedly diminished survival curve shoulder (Do = 1.40 Gy, n = 1.0). Different hormonal manipulations of cycling human breast carcinoma cells may have profound but disparate effects on radiosensitivity such that tamoxifen and estrogens may serve as useful agents with which to study the biochemical mechanisms of repair.

This article has been cited by other articles:

				M. Isomura, N. Oya, S. Tachiiri, Y. Kaneyasu, Y. Nishimura, T. Akimoto, M. Hareyama, T. Sugita, N. Mitsuhashi, T. Yamashita, et al. IL12RB2 and ABCA1 Genes Are Associated with Susceptibility to Radiation Dermatitis Clin. Cancer Res., October 15, 2008; 14(20): 6683 - 6689. [Abstract] [Full Text] [PDF]

				O. Riesterer, L. Milas, and K. K. Ang Use of Molecular Biomarkers for Predicting the Response to Radiotherapy With or Without Chemotherapy J. Clin. Oncol., September 10, 2007; 25(26): 4075 - 4083. [Abstract] [Full Text] [PDF]

				T. Whelan and M. Levine Radiation Therapy and Tamoxifen: Concurrent or Sequential? That Is the Question J. Clin. Oncol., January 1, 2005; 23(1): 1 - 4. [Full Text] [PDF]

				E. E.R. Harris, V. J. Christensen, W.-T. Hwang, K. Fox, and L. J. Solin Impact of Concurrent Versus Sequential Tamoxifen With Radiation Therapy in Early-Stage Breast Cancer Patients Undergoing Breast Conservation Treatment J. Clin. Oncol., January 1, 2005; 23(1): 11 - 16. [Abstract] [Full Text] [PDF]

				P. H. Ahn, H. T. Vu, D. Lannin, E. Obedian, M. P. DiGiovanna, B. Burtness, and B. G. Haffty Sequence of Radiotherapy With Tamoxifen in Conservatively Managed Breast Cancer Does Not Affect Local Relapse Rates J. Clin. Oncol., January 1, 2005; 23(1): 17 - 23. [Abstract] [Full Text] [PDF]

				L. J. Pierce, L. F. Hutchins, S. R. Green, D. L. Lew, J. R. Gralow, R. B. Livingston, C. K. Osborne, and K. S. Albain Sequencing of Tamoxifen and Radiotherapy After Breast-Conserving Surgery in Early-Stage Breast Cancer J. Clin. Oncol., January 1, 2005; 23(1): 24 - 29. [Abstract] [Full Text] [PDF]

				J. A. Mobley and R. W. Brueggemeier Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer Carcinogenesis, January 1, 2004; 25(1): 3 - 9. [Abstract] [Full Text] [PDF]